In this episode, Dr. Douglas Graham, Chief of the Aflac Cancer and Blood Disorders Center, shares progress in pediatric leukemia and sickle cell disease treatments, the impact of a 30-year partnership with Aflac, and breakthroughs in precision medicine, CAR T-cell therapy, and gene therapy that are reshaping outcomes for children and families.
Dr. Douglas Graham, Chief of the Aflac Cancer and Blood Disorders Center
Next Up in Becker’s Pediatric Leadership Podcast
-
In this episode, Bryan Croft, Executive Vice President of Hospital Operations and Chief Operating Officer at Cedars-Sinai Health System, joins…
-
This episode recorded live at the Becker’s 11th Annual Health IT + Digital Health + RCM Conference features Isaiah Nathaniel,…
-
In this episode, Marcelo Hochman, MD, Surgeon and Healthcare Policy & Private Practice Expert, Hochman Private Practice Advisory, discusses the…
Comments are closed.